Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Fairfax. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Fairfax at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The purpose of this multicentric, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy of TUB-040 and to find the best dose of TUB-040 in patients with ovarian cancer and Non Small Cell Lung Cancer. TUB-040 is an antibody-drug-conjugate which delivers a topoisomerase I inhibitor to tumor cells which overexpress the target NaPi2b. The study consists of two parts: In dose escalation, ovarian cancer patients and lung cancer patients rece
Sponsor: Tubulis GmbH
Check if you qualify for this ovarian cancer clinical trial in Fairfax, VA
If you're searching for ovarian cancer treatment options in Fairfax, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairfax research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.